Mr. Christopher T. Dunne

Columbia, MD - July 7, 1997 - GENE LOGIC INC. announced that it has promoted Christopher T. Dunne, CPA, to Director, Finance & Administration from his previous position as Controller.In his new position, Mr. Dunne will oversee GENE LOGIC'S financial planning, accounting and administrative activities.

Prior to joining GENE LOGIC in 1996, Mr. Dunne was a Senior Project Accountant for The John Akridge Companies, responsible for the accounting activities of a portfolio of commercial real estate partnerships and corporations located in the Washington, D.C. metropolitan area.

From 1990 to 1994, Chris Dunne was employed by Deloitte & Touche LLP where he had audit responsibilities for a number of public and private biotechnology companies, including preparation for initial public offerings and SEC reporting.He received his B.S. degree in Business Management, Accounting from the University of Maryland, College Park, MD, in 1990 and Certified Public Accountant designation in 1991.

Gene Logic Inc Promotes Christopher T. Dunne , CPA to Director , Finance & AdministrationGene Logic Inc.Investor Relations

...
Gene Logic Inc Promotes Christopher T. Dunne , CPA to Director , Finance & Administration.

Columbia , MD - July 7 , 1997 - GENE LOGIC INC. announced that it has promoted Christopher T. Dunne , CPA , to Director , Finance & Administration from his previous position as Controller.In his new position , Mr. Dunne will oversee GENE LOGIC'S financial planning , accounting and administrative activities.

Prior to joining GENE LOGIC in 1996 , Mr. Dunne was a Senior Project Accountant for The John Akridge Companies , responsible for the accounting activities of a portfolio of commercial real estate partnerships and corporations located in the Washington , D.C. metropolitan area.

From 1990 to 1994 , Chris Dunne was employed by Deloitte & Touche LLP where he had audit responsibilities for a number of public and private biotechnology companies , including preparation for initial public offerings and SEC reporting.He received his B.S. degree in Business Management , Accounting from the University of Maryland , College Park , MD , in 1990 and Certified Public Accountant designation in 1991.

GENE LOGIC is a high-throughput , functional genomics company using a new system based on analysis of gene expression and gene regulation to accelerate the discovery of novel drug targets and drug leads.The core of GENE LOGIC'S Accelerated Target Discovery platform is a unique technology for monitoring the expression level of every gene in a given tissue or cell type with a high degree of sensitivity , reliability and accuracy.Analyzing these data using its Molecular Topography tool , GENE LOGIC is able to produce a complete , quantitative picture of all the genes used in a human cell.In its target discovery process , GENE LOGIC creates ìmolecular movies , î a series of molecular topographies , which show the changes in gene expression patterns as a disease develops and progresses in a specific cell or tissue type , across different cell types , and in cells treated with various drugs or experimental compounds.By analyzing these changes using proprietary bioinformatics software , GENE LOGIC can identify rapidly which expressed genes are implicated in a disease and provide more novel targets for drug discovery in a shorter time and at a lower cost than any competing technology.